Key result
VR-CBT triples short-term anxiety response post-AMI vs control, but benefits fade by 3 months.
Why the study?
Does 1-week immersive virtual reality-based cognitive behavioural therapy improve anxiety response rates, depressive symptoms, and biomarkers without cardiac safety signals in hospitalized patients after acute myocardial infarction?
RCT (n=136)
No
Does 1-week immersive virtual reality-based cognitive behavioural therapy improve anxiety response rates, depressive symptoms, and biomarkers without cardiac safety signals in hospitalized patients after acute myocardial infarction?
A 1-week course of VR-CBT in hospitalized post-AMI patients safely achieves substantial short-term anxiety responder rates (59.7% vs 17.6%), though the benefit diminishes by 3 months post-discharge.
Answers are grounded in this paper and cite their sources.
Offers safe short-term VR-CBT for post-AMI anxiety; extends RCT evidence but leaves durability open.
BACKGROUND: Anxiety after acute myocardial infarction (AMI) worsens prognosis. A randomized trial showed that 1-week immersive virtual reality-based cognitive behavioural therapy (VR-CBT) reduces anxiety in hospitalized patients with AMI; its primary results are published. This secondary analysis examined responder rates, depressive symptoms, biomarkers, cardiac safety, and response prediction. METHODS: The completer set (62 VR-CBT, 74 control) was analyzed. Response was a Hamilton Anxiety Rating Scale (HAMA) reduction ≥50%. Biomarkers, impedance cardiography, and 12‑lead electrocardiography were assessed. Seven machine-learning models and a LASSO-based nomogram were compared (stratified 5-fold cross-validation ×3); a linear mixed model (LMM) assessed HAMA trajectories. RESULTS: Response rates at end of intervention were 59.7% vs 17.6% (P < 0.001). At 3 months the responder endpoint did not differ (35.6% vs 38.2%, P = 0.902), even after baseline adjustment (adjusted OR 0.61, P = 0.246); only the adjusted LMM suggested a marginal residual effect (B = -2.41, P = 0.048). Depressive symptoms improved more with VR-CBT (P < 0.001). IL-6 declined in both groups (borderline greater with VR-CBT, P = 0.051). No hemodynamic or arrhythmic safety signal emerged in the available data; QTc change favored VR-CBT (P = 0.016). The nomogram (treatment allocation, marital status, baseline HAMA) discriminated best (pooled area under the receiver operating characteristic curve [AUC] 0.762). LIMITATIONS: Single-center, complete-case secondary analysis; baseline symptom imbalance; no external validation of prediction models. CONCLUSIONS: VR-CBT after AMI produced substantial short-term responder-level gains and no cardiac safety signal; whether the benefit persists after discharge remains uncertain. An interpretable nomogram may help clinicians estimate individual response likelihood with versus without VR-CBT.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2026) conducted an RCT in Anxiety after acute myocardial infarction (AMI) (n=136). Immersive virtual reality-based cognitive behavioural therapy (VR-CBT) vs. Control was evaluated on Anxiety response defined as a Hamilton Anxiety Rating Scale (HAMA) reduction ≥50% at the end of the 1-week intervention (p=<0.001). 1-week VR-CBT increased short-term anxiety response rates post-AMI vs control, though 3-month responder rates did not differ.
Synapse has enriched 10 related papers. Consider them for comparative context: